![Joseph Leveque](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joseph Leveque
Chief Executive Officer at
Medikine, Inc.
Profile
Joseph A. Leveque occupies the position of Chief Medical Officer of Mirati Therapeutics, Inc. Dr. Leveque previously occupied the position of Medical Director of Amgen, Inc. and Vice President-Medical & Scientific Affairs at Onyx Pharmaceuticals, Inc. (a subsidiary of Amgen, Inc.), Vice President at Bristol Myers Squibb Co., Chief Medical Officer at EMD Serono, Inc., Chief Medical Officer of ARMO BioSciences, Inc., Chief Medical Officer of Synthorx, Inc. and VP-Oncology Medical & Scientific Affairs at Cephalon, Inc. He received a doctorate from The University of Texas at Austin, an undergraduate degree from Santa Clara University and an MBA from The Wharton School of the University of Pennsylvania.
Joseph Leveque active positions
| Companies | Position | Start |
|---|---|---|
ImmunOs Therapeutics AG
 ImmunOs Therapeutics AG BiotechnologyHealth Technology Engages in discovering and developing novel human immunomodulatory proteins | Director/Board Member | 2022-10-03 |
Medikine, Inc.
 Medikine, Inc. Pharmaceuticals: MajorHealth Technology Operates as preclinical-stage biopharmaceutical company | Chief Executive Officer | 2021-12-31 |
Former positions of Joseph Leveque
| Companies | Position | End |
|---|---|---|
| MIRATI THERAPEUTICS | Chief Tech/Sci/R&D Officer | 2021-10-31 |
| SYNTHORX, INC. | Chief Tech/Sci/R&D Officer | 2020-01-22 |
| ARMO BIOSCIENCES INC | Chief Tech/Sci/R&D Officer | 2018-06-20 |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Chief Tech/Sci/R&D Officer | 2017-11-30 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 2014-12-31 |
Training of Joseph Leveque
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
63
1st degree connections
13
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 13 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops cancer therapies | Health Technology |
The University of Texas at Austin
 The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Santa Clara University
 Santa Clara University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ARMO BioSciences, Inc.
 ARMO BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapy for treatment of cancer | Health Technology |
Synthorx, Inc.
 Synthorx, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that uses synthetic biology to discover and develop protein therapeutics | Health Technology |
ImmunOs Therapeutics AG
ImmunOs Therapeutics AG BiotechnologyHealth Technology Engages in discovering and developing novel human immunomodulatory proteins | Health Technology |
Medikine, Inc.
Medikine, Inc. Pharmaceuticals: MajorHealth Technology Operates as preclinical-stage biopharmaceutical company | Health Technology |
- Stock Market
- Insiders
- Joseph Leveque
